01 15SUMITOMO PHARMA
01 27300935
02 28058280
03 110350170
04 110449191
05 110786501
06 111033551
07 111583526
08 111793812
09 211795178
10 111957684
11 112097198
12 112144809
01 6Y
02 9Blank
01 5Y
02 10Blank
01 42026-01-28
02 22033-09-27
03 12036-02-25
04 72037-09-29
05 12038-05-03
Patent Expiration Date : 2037-09-29
US Patent Number : 12144809
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-4035
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
US Patent Number : 11583526
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2038-05-03
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 11793812
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-2360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-05-03
Patent Expiration Date : 2037-09-29
US Patent Number : 12097198
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
US Patent Number : 10449191
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
US Patent Number : 10786501
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 11033551
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-3129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 11957684
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-3129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2026-01-28
US Patent Number : 7300935
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 214621
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-01-28
Patent Expiration Date : 2033-09-27
US Patent Number : 11795178
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214621
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-09-27
